The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review

Ryosuke Yamauchi(Kurume University), Takuji Torimura(Omuta hospital), Tetsuhiro Yoshimura(Kurume University), Keiichi Mitsuyama(Kurume University), Takaaki Tokito(Kurume University), Shinichiro Yoshioka(Kurume University), Atsushi Mori(Kurume University), Osamu Tsuruta(Kurume University), Hidenobu Ishii(Kurume University), Toshihiro Araki(Kurume University), Kotaro Kuwaki(Kurume University)
BMC Gastroenterology
August 31, 2018
10.1186/s12876-018-0864-1
Cited by 56

Related Papers

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600